Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Article

  • Article
    p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas
    Jian-Zhong Qin, Lawrence Stennett, Patricia Bacon, Barbara Bodner, Mary J.C. Hendrix, Richard E.B. Seftor, Elisabeth A. Seftor, Naira V. Margaryan, Pamela M. Pollock, Amy Curtis, Jeffrey M. Trent, Frank Bennett, Lucio Miele and Brian J. Nickoloff
    Mol Cancer Ther August 1 2004 3 (8) 895-902;

  • Article
    Characterization of inhibitors of specific carboxylesterases: Development of carboxylesterase inhibitors for translational application
    Kyoung Jin P. Yoon, Janice L. Hyatt, Christopher L. Morton, Richard E. Lee, Philip M. Potter and Mary K. Danks
    Mol Cancer Ther August 1 2004 3 (8) 903-909;

  • Article
    The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer
    Terry Y-K. Chow, Moulay A. Alaoui-Jamali, Chiaoli Yeh, Leonard Yuen and David Griller
    Mol Cancer Ther August 1 2004 3 (8) 911-920;

  • Article
    Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
    Daniel E.H. Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O'Hara, David Powers, Robert B. DuBridge, Ingrid Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordon-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan and Debbie A. Law
    Mol Cancer Ther August 1 2004 3 (8) 921-932;

  • Article
    Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery
    Vaqar Mustafa Adhami, Moammir Hasan Aziz, Shannon R. Reagan-Shaw, Minakshi Nihal, Hasan Mukhtar and Nihal Ahmad
    Mol Cancer Ther August 1 2004 3 (8) 933-940;

  • Article
    Polyomavirus middle T–induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes
    Jeannie E. Maglione, Erik T. McGoldrick, Lawrence J.T. Young, Ruria Namba, Jeffrey P. Gregg, Lin Liu, Drew Moghanaki, Lesley G. Ellies, Alexander D. Borowsky, Robert D. Cardiff and Carol L. MacLeod
    Mol Cancer Ther August 1 2004 3 (8) 941-953;

  • Article
    Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells
    Mikael Rinne, David Caldwell and Mark R. Kelley
    Mol Cancer Ther August 1 2004 3 (8) 955-967;

  • Article
    Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti–vascular endothelial growth factor receptor-2 antibody
    Alexander L. Rakhmilevich, Andrea T. Hooper, Daniel J. Hicklin and Paul M. Sondel
    Mol Cancer Ther August 1 2004 3 (8) 969-976;

  • Article
    Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
    David Raben, Cataldo Bianco, Vincenzo Damiano, Roberto Bianco, Davide Melisi, Chiara Mignogna, Francesco Paolo D'Armiento, Luca Cionini, A. Raffaele Bianco, Giampaolo Tortora, Fortunato Ciardiello and Paul Bunn
    Mol Cancer Ther August 1 2004 3 (8) 977-983;

  • Article
    Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells
    Anupama Munshi, John F. Kurland, Takashi Nishikawa, Paul J. Chiao, Michael Andreeff and Raymond E. Meyn
    Mol Cancer Ther August 1 2004 3 (8) 985-992;

  • Article
    Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets
    Cathrine M. Holland, Samir A. Saidi, Amanda L. Evans, Andrew M. Sharkey, John A. Latimer, Robin A.F. Crawford, D. Stephen Charnock-Jones, Cristin G. Print and Stephen K. Smith
    Mol Cancer Ther August 1 2004 3 (8) 993-1001;

  • Article
    Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation
    Liang Liu, Joel B. Berletch, Jessica G. Green, Mitchell S. Pate, Lucy G. Andrews and Trygve O. Tollefsbol
    Mol Cancer Ther August 1 2004 3 (8) 1003-1009;

  • Article
    Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment
    Joshua P. Klopper, William R. Hays, Vibha Sharma, Margaret A. Baumbusch, Jerome M. Hershman and Bryan R. Haugen
    Mol Cancer Ther August 1 2004 3 (8) 1011-1020;

Minireview

  • Minireview
    Altered Hsp90 function in cancer: A unique therapeutic opportunity
    Rochelle Bagatell and Luke Whitesell
    Mol Cancer Ther August 1 2004 3 (8) 1021-1030;

  • Minireview
    Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?
    Mark A. Hull, Stanley C.W. Ko and Gillian Hawcroft
    Mol Cancer Ther August 1 2004 3 (8) 1031-1039;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 3 (8)
August 2004
Volume 3, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Jump to

  • Article
  • Minireview
Advertisement
  • Most Cited
  • Most Read
Loading
  • Anti-KIT DNA Aptamer Labeling in GIST
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Tipifarnib as a Precision Therapy for HRAS-Mutant HNSCC
  • Targeted Delivery of MMAE Using Bicycle Molecules
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement